Skip to main content
Top
Published in: Pediatric Cardiology 5/2012

01-06-2012 | Case Report

Incomplete and Atypical Kawasaki Disease: A Clinicopathologic Paradox at High Risk of Sudden and Unexpected Infant Death

Authors: Angela Pucci, Silvana Martino, Maria Tibaldi, Giovanni Bartoloni

Published in: Pediatric Cardiology | Issue 5/2012

Login to get access

Abstract

Incomplete Kawasaki disease (IKD) and atypical Kawasaki disease (AKD) represent rare conditions. Two cases of unexpected or sudden infant death are reported. The diagnosis for a 3-month-old girl was determined by echocardiography, and the child unexpectedly died despite appropriate treatment, whereas autopsy determined the diagnosis of AKD for a 4-month-old boy. In both patients, giant coronary artery aneurysms with thrombosis and vasculitis, myocarditis, and coagulative necrosis were shown at autopsy. These rare forms of IKD and AKD carry a poor prognosis and represent a paradox between the severe cardiovascular damage and the clinical presentation that mimics common and usually self-limiting exanthematic infectious disease in infancy.
Literature
1.
go back to reference Choueiter NF, Olson AK, Shen DD, Portman MA (2010) Prospective open-label trial of etanercept as adjunctive therapy for Kawasaki disease. J Pediatr 157:960–966PubMedCrossRef Choueiter NF, Olson AK, Shen DD, Portman MA (2010) Prospective open-label trial of etanercept as adjunctive therapy for Kawasaki disease. J Pediatr 157:960–966PubMedCrossRef
2.
go back to reference Diana MC, Villa G, Gattorno M, Ottonello G, Costabel S, Savioli C, DiPietro P (2006) Sudden death in an infant revealing atypical Kawasaki disease. Pediatr Emerg Care 22:35–37PubMedCrossRef Diana MC, Villa G, Gattorno M, Ottonello G, Costabel S, Savioli C, DiPietro P (2006) Sudden death in an infant revealing atypical Kawasaki disease. Pediatr Emerg Care 22:35–37PubMedCrossRef
3.
go back to reference Furuno K, Yuge T, Kusuhara K, Takada H, Nishio H, Khajoee V, Ohno T, Hara T (2004) CD25+ CD4+ regulatory T cells in patients with Kawasaki disease. J Pediatr 145:385–390PubMedCrossRef Furuno K, Yuge T, Kusuhara K, Takada H, Nishio H, Khajoee V, Ohno T, Hara T (2004) CD25+ CD4+ regulatory T cells in patients with Kawasaki disease. J Pediatr 145:385–390PubMedCrossRef
4.
go back to reference Lie JT, Sanders JA (1997) Kawasaki disease: sudden death in early infancy from accelerated late sequelae of coronary artery aneurysms. Cardiovasc Pathol 6:175–178CrossRef Lie JT, Sanders JA (1997) Kawasaki disease: sudden death in early infancy from accelerated late sequelae of coronary artery aneurysms. Cardiovasc Pathol 6:175–178CrossRef
5.
go back to reference Manlhiot C, Yeung RS, Clarizia NA, Chahal N, McCrindle BW (2009) Kawasaki disease at the extremes of the age spectrum. Pediatrics 124:410–415CrossRef Manlhiot C, Yeung RS, Clarizia NA, Chahal N, McCrindle BW (2009) Kawasaki disease at the extremes of the age spectrum. Pediatrics 124:410–415CrossRef
6.
go back to reference Maresi E, Passantino R, Midulla R, Ottoveggio G, Orlando E, Becchina G, Meschis L, Amato G (2001) Sudden infant death caused by a ruptured coronary aneurysm during acute phase of atypical Kawasaki disease. Hum Pathol 32:1407–1409PubMedCrossRef Maresi E, Passantino R, Midulla R, Ottoveggio G, Orlando E, Becchina G, Meschis L, Amato G (2001) Sudden infant death caused by a ruptured coronary aneurysm during acute phase of atypical Kawasaki disease. Hum Pathol 32:1407–1409PubMedCrossRef
7.
go back to reference Newburger JW, Sleeper RA, McCrindle BW, Minich LL, Gersony W, Vetter VL, Atz AM, Li JS, Takahashi M, Baker AL, Colan SD, Mitchell PD, Klein GL, Sundel RP, Pediatric Heart Network Investigators (2007) Randomized trial of pulsed corticosteroids therapy for primary treatment of Kawasaki disease. N Engl J Med 356:663–675PubMedCrossRef Newburger JW, Sleeper RA, McCrindle BW, Minich LL, Gersony W, Vetter VL, Atz AM, Li JS, Takahashi M, Baker AL, Colan SD, Mitchell PD, Klein GL, Sundel RP, Pediatric Heart Network Investigators (2007) Randomized trial of pulsed corticosteroids therapy for primary treatment of Kawasaki disease. N Engl J Med 356:663–675PubMedCrossRef
8.
go back to reference Pannaraj PS, Turner CL, Bastian JF, Burns JC (2004) Failure to diagnose Kawasaki disease at the extremes of the pediatric age range. Pediatr Infect Dis J 23:789–791PubMedCrossRef Pannaraj PS, Turner CL, Bastian JF, Burns JC (2004) Failure to diagnose Kawasaki disease at the extremes of the pediatric age range. Pediatr Infect Dis J 23:789–791PubMedCrossRef
9.
go back to reference Pucci A, Martino S, Celeste A, Linari A, Tibaldi M, Camosso E, Muscio M, Barattia G, Riva C, Bartoloni G (2008) Angiogenesis, tumor necrosis factor-alpha, and procoagulant factors in coronary artery giant aneurysm of a fatal infantile Kawasaki disease. Cardiovasc Pathol 17:186–189PubMedCrossRef Pucci A, Martino S, Celeste A, Linari A, Tibaldi M, Camosso E, Muscio M, Barattia G, Riva C, Bartoloni G (2008) Angiogenesis, tumor necrosis factor-alpha, and procoagulant factors in coronary artery giant aneurysm of a fatal infantile Kawasaki disease. Cardiovasc Pathol 17:186–189PubMedCrossRef
10.
11.
go back to reference Vanlieferinghen PH, Brunet F, Beaufrère AM, Borderon C, Déchelotte P (2002) Sudden unexpected death in an infant due to a ruptured coronary aneurysm revealing Kawasaki disease. Arch de Pédiatrie 9:1248–1251CrossRef Vanlieferinghen PH, Brunet F, Beaufrère AM, Borderon C, Déchelotte P (2002) Sudden unexpected death in an infant due to a ruptured coronary aneurysm revealing Kawasaki disease. Arch de Pédiatrie 9:1248–1251CrossRef
12.
go back to reference Weiss JE, Eberhard BA, Chowdhury D, Gottlieb BS (2004) Infliximab as a novel therapy for refractory Kawasaki disease. J Rheumatol 31:808–810PubMed Weiss JE, Eberhard BA, Chowdhury D, Gottlieb BS (2004) Infliximab as a novel therapy for refractory Kawasaki disease. J Rheumatol 31:808–810PubMed
13.
go back to reference Yellen ES, Gauvreau K, Takahashi M, Burns JC, Shulman S, Baker AL, Innocentini N, Zambetti C, Pancheri JM, Ostrow A, Frazer JR, Sundel RP, Fulton DR, Newburger JW (2010) Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease. Pediatrics 125:e234–e241PubMedCrossRef Yellen ES, Gauvreau K, Takahashi M, Burns JC, Shulman S, Baker AL, Innocentini N, Zambetti C, Pancheri JM, Ostrow A, Frazer JR, Sundel RP, Fulton DR, Newburger JW (2010) Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease. Pediatrics 125:e234–e241PubMedCrossRef
Metadata
Title
Incomplete and Atypical Kawasaki Disease: A Clinicopathologic Paradox at High Risk of Sudden and Unexpected Infant Death
Authors
Angela Pucci
Silvana Martino
Maria Tibaldi
Giovanni Bartoloni
Publication date
01-06-2012
Publisher
Springer-Verlag
Published in
Pediatric Cardiology / Issue 5/2012
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-012-0186-y

Other articles of this Issue 5/2012

Pediatric Cardiology 5/2012 Go to the issue

From Other Journals

From Other Journals